Nanobiomedicine
SJR0.186
GB
GBJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.186 | Q4 | 24.8% | |
| 2024 | — | — | 0.523 | Q2 | 63.7% | |
| 2023 | — | — | 0.482 | Q3 | 63.6% | |
| 2022 | — | — | 0.880 | Q1 | 83.2% | |
| 2021 | — | — | 0.692 | Q2 | 77.1% | |
| 2020 | — | — | 0.561 | Q2 | 69.9% | |
| 2019 | — | — | 0.453 | Q3 | 64.5% | |
| 2018 | — | — | 0.533 | Q2 | 67.2% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
ISSN
1849-5435
country
GBcoverage
2014-2022